We are live on ! Find out more
BIA

Biondo Investment Advisors Portfolio holdings

AUM $780M
1-Year Est. Return 21.03%
This Fund
S&P 500
This Quarter Est. Return
+10.38%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.37%
AUM
$302M
AUM Growth
+$6.74M
Cap. Flow
-$7.25M
Cap. Flow %
-2.4%
Top 10 Hldgs %
48.03%
Holding
81
New
4
Increased
36
Reduced
26
Closed
6

Sector Composition

Rank Sector Weight
1 Healthcare 26.04%
2 Financials 13.65%
3 Energy 11.95%
4 Communication Services 10.49%
5 Technology 7.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MA icon
1
Mastercard
MA
$484B
$22.9M 7.56%
221,329
-3,970
-2% -$411K
ISRG icon
2
Intuitive Surgical
ISRG
$125B
$18.9M 6.24%
267,570
-24,894
-9% -$1.83M
CELG
3
DELISTED
Celgene Corp
CELG
$16.5M 5.44%
142,202
-840
-0.6% -$93.5K
BAC.WS.A
4
DELISTED
Bank Of America Corporation Ws A
BAC.WS.A
$15.6M 5.15%
1,563,855
-7,100
-0.5% -$52.3K
AAPL icon
5
Apple
AAPL
$4.8T
$15.4M 5.1%
533,004
-7,588
-1% -$215K
JPM.WS
6
DELISTED
JPMorgan Chase
JPM.WS
$13.8M 4.57%
312,002
-63,385
-17% -$2.19M
META icon
7
Meta Platforms (Facebook)
META
$1.64T
$12.6M 4.18%
109,835
+4,885
+5% +$600K
JPM icon
8
JPMorgan Chase
JPM
$901B
$11M 3.64%
127,413
-3,580
-3% -$273K
IDXX icon
9
Idexx Laboratories
IDXX
$44.5B
$9.59M 3.17%
81,746
+1,125
+1% +$128K
GOOGL icon
10
Alphabet (Google) Class A
GOOGL
$4.3T
$9.05M 2.99%
228,360
+81,700
+56% +$3.27M
SLB icon
11
SLB Ltd
SLB
$69.4B
$8.19M 2.71%
97,574
+775
+0.8% +$63.5K
FANG icon
12
Diamondback Energy
FANG
$55B
$7.46M 2.47%
73,802
+980
+1% +$97.8K
BMY icon
13
Bristol-Myers Squibb
BMY
$123B
$6.24M 2.06%
106,828
-19,092
-15% -$1.04M
CVX icon
14
Chevron
CVX
$378B
$5.73M 1.89%
48,647
+155
+0.3% +$16.9K
CLB icon
15
Core Laboratories
CLB
$516M
$5.33M 1.76%
44,427
-90
-0.2% -$9.96K
EGRX
16
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$5.04M 1.67%
+63,575
New +$4.62M
ILMN icon
17
Illumina
ILMN
$27.9B
$4.76M 1.57%
38,189
-9,667
-20% -$1.3M
VZ icon
18
Verizon
VZ
$182B
$4.67M 1.54%
87,468
+9,970
+13% +$498K
VFC icon
19
VF Corp
VFC
$6.62B
$4.6M 1.52%
91,627
-1,206
-1% -$62.5K
PCRX icon
20
Pacira BioSciences
PCRX
$997M
$4.6M 1.52%
142,473
-20,600
-13% -$687K
REGN icon
21
Regeneron Pharmaceuticals
REGN
$70.5B
$4.38M 1.45%
11,935
+465
+4% +$177K
LMT icon
22
Lockheed Martin
LMT
$117B
$4.36M 1.44%
17,448
+200
+1% +$50K
MMM icon
23
3M
MMM
$83B
$3.98M 1.32%
26,631
+110
+0.4% +$15.9K
PM icon
24
Philip Morris
PM
$300B
$3.97M 1.31%
43,391
+649
+2% +$60.1K
ABBV icon
25
AbbVie
ABBV
$448B
$3.77M 1.25%
60,172
+687
+1% +$41.9K

Similar funds

Biondo Investment Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, Biondo Investment Advisors held 81 positions worth $302M, up 2.3% from $296M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Biondo Investment Advisors's Q4 2016 filing shows 4 new, 36 increased, 26 reduced and 6 closed positions. Its largest new stake was Eagle Pharmaceuticals, Inc.: 63,575 shares worth $5.04M. The largest sale was Ford, an estimated $4.01M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 30% a quarter earlier, followed by Financials and Energy.

  • Biondo Investment Advisors's largest Q4 2016 buy was Eagle Pharmaceuticals, Inc.: 63,575 shares worth $5.04M.
  • Biondo Investment Advisors added most to Alphabet (Google) Class A in Q4 2016, an estimated $3.27M increase.
  • Biondo Investment Advisors's biggest Q4 2016 reduction was Ford, cutting an estimated $4.01M.
  • Biondo Investment Advisors fully exited Vertex Pharmaceuticals in Q4 2016, selling an estimated $3.8M.
  • Biondo Investment Advisors's ten largest holdings make up 48% of its $302M portfolio in Q4 2016.
  • Biondo Investment Advisors opened 4 new positions and closed 6 in Q4 2016.
  • Biondo Investment Advisors's portfolio value rose 2.3% quarter-over-quarter to $302M.

Based on Biondo Investment Advisors's 13F filing for Q4 2016, filed 6 Feb 2017.